Whitehawk director Iyengar reports no holdings

New director Vijay K. Iyengar filed an initial Form 3 for Whitehawk Therapeutics with no reported share holdings or transactions.

Rhea-AI Filing Summary

Whitehawk Therapeutics, Inc. (WHWK) reported an initial statement of beneficial ownership for Vijay K. Iyengar, who is identified as a director of the company. The filing reports no equity transactions, derivative positions, or holdings as of the Form 3 reporting date.

Key Figures

Reported equity transactions: 0 Reported derivative transactions: 0 Net buy/sell shares: 0 shares

3 metrics

Reported equity transactions 0 Initial Form 3 statement of beneficial ownership for director Vijay K. Iyengar

Reported derivative transactions 0 Initial Form 3 statement of beneficial ownership for director Vijay K. Iyengar

Net buy/sell shares 0 shares Transaction summary shows neutral net direction

Key Terms

Form 3, beneficial ownership, Power of Attorney

3 terms

Form 3 regulatory

"reported an initial statement of beneficial ownership for Vijay K. Iyengar"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"reported an initial statement of beneficial ownership for Vijay K. Iyengar"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Power of Attorney regulatory

"The remarks section references “Exhibit 24 - Power of Attorney”"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for WHWK by Vijay K. Iyengar show?

It shows that Vijay K. Iyengar is a director of Whitehawk Therapeutics, Inc. and, as of this initial beneficial ownership report, no equity holdings or transactions are reported for him.

Does the WHWK Form 3 report any stock purchases or sales by Vijay K. Iyengar?

No. The Form 3 for Whitehawk Therapeutics, Inc. reports no transactions, with buy, sell, acquire, dispose, and other transaction counts all shown as zero.

Are any derivative securities reported for Vijay K. Iyengar in WHWK?

No. The filing’s derivative summary is empty, and the transaction summary reports zero derivative transactions and zero exercise shares for Whitehawk Therapeutics, Inc.

What insider role does Vijay K. Iyengar have at Whitehawk Therapeutics (WHWK)?

The Form 3 identifies Vijay K. Iyengar as a director of Whitehawk Therapeutics, Inc., with no officer position or ten percent owner status indicated.

Does the WHWK Form 3 mention a Rule 10b5-1 trading plan for Vijay K. Iyengar?

No. The document-level indicator for a Rule 10b5-1 plan is null, and there are no transactions or footnotes describing any trading plan.

What additional document is referenced in the WHWK Form 3 for Vijay K. Iyengar?

The remarks section references “Exhibit 24 - Power of Attorney”, indicating that a power of attorney related to the filing is included as an exhibit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:03 PM Accepted by SEC EDGAR 09/11/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Iyengar Vijay K

(Last) (First) (Middle)

C/O WHITEHAWK THERAPEUTICS, INC.

2 HEADQUARTERS PLAZA, EAST BLDG, 11 FL

(Street)

MORRISTOWN NEW JERSEY 07960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/09/2026

3. Issuer Name and Ticker or Trading Symbol
Whitehawk Therapeutics, Inc. [ WHWK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Stephen Rodin, as Attorney-in-Fact	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)